News

At the 2024 SDPA Fall Conference, Hilary Baldwin, MD highlighted the superiority of branded acne therapies, the necessity of tailored regimens, and the value of structured PA education.

Take this quiz to see if you are leveraging the latest research in acne treatment.

At the SDPA Fall Conference, Miranti emphasized the importance of targeted, comprehensive acne therapies and inspired attendees to embrace pediatric dermatology as a rewarding subspecialty.

Catch up on coverage from the third day of the 2024 Society of Dermatology Physician Associates Fall Conference in Las Vegas, Nevada.

At the 2024 SDPA Fall Conference, Audrey Rutherford, MD, discussed the critical role of vulvar biopsies in identifying cancer and other conditions to improve patient outcomes for underdiagnosed vulvar conditions.

Zirwas spoke with Dermatology Times to share the top clinical pearls and key takeaways from his discussion on contact dermatitis.

At the 2024 SDPA Fall Conference, Renata Block, MMS, PA-C, emphasized the power of membership, tailored education, interdisciplinary collaboration, and advocacy in shaping the future of dermatology to improve patient outcomes.

Jane Mast, PhD, DMSc, MPAS, shares her thoughts on the award, being a Derm PA, and dermatology.

Post-hoc analysis demonstrated secukinumab's efficacy in addressing both HS and HS-related psychiatric symptoms.

At the 2024 SDPA Fall Conference, Tracey Vlahovic, DPM, highlighted the need for interdisciplinary collaboration in nail disorder management, underscoring the importance of mutual learning between podiatry and dermatology.

Catch up on coverage from the second day of the 2024 Society of Dermatology Physician Associates Fall Conference in Las Vegas, Nevada.

At the 2024 SDPA Fall Conference, Sara Wilchowski, DMSc, MPAS, PA-C, highlighted the challenges and rewards of transitioning to industry roles, the impact of “Insta-Tok” on patient care, and the evolving landscape of dermatology.

Dermatology physician associates via DPAF conduct skin checks at the Sun Bus during the Fall Conference.

A poster presented at the 2024 SDPA Fall Conference demonstrated that clascoterone cream remains stable when paired with commonly prescribed acne topicals, supporting its role in multimodal therapy.

Michael Rubio, PA-C, previews the transformative programming and career-focused initiatives at this year’s Society of Dermatology Physician Associates Fall Conference in Las Vegas.

The target action date for the FDA decision is April 18, 2025.

Catch up on coverage from the first day of the 2024 Fall Society of Dermatology Physician Associates Conference in Las Vegas, Nevada.

Zirwas presented 2 sessions at SDPA on innovative care strategies for patients with AD and other itch-related diseases.

Share with us the topics you want to learn more about at SDPA Fall.

The Hidradenitis Suppurativa Foundation offers grants for HS research and clinical expertise, supporting early-stage to established investigators.

Block emphasized the importance of breakout sessions geared toward varying levels of experience—beginner, intermediate, and advanced.

Delgocitinib is indicated for adults with CHE who either do not respond to or cannot use topical corticosteroids.

The conference aimed at providing physician assistants with the latest in dermatology advancements begins today in Las Vegas, Nevada.

November is Hyperhidrosis Awareness Month - test your knowledge on the subject.

The study calls for improved diversity in clinical training materials to help future clinicians better recognize conditions on darker skin.

Join Dermatology Times in celebrating National Healthy Skin Month.

A study showed NB-UVB phototherapy effectively reduced prurigo nodularis symptoms, with 80% of patients achieving full response.

A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.

RAD will join MJH's multichannel model, enhancing its educational impact in atopic dermatitis, alopecia areata, vitiligo, and eczema.

Abeona's pz-cel has been granted a April 29, 2025, PDUFA date.